About 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide
4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide (PubChem CID 155517824) has the molecular formula C30H31F3N6OS
and a molecular weight of 580.68 g/mol. Its IUPAC name is 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide.
Molecular Properties
| Compound Name | 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide |
| PubChem CID | 155517824 |
| Molecular Formula | C30H31F3N6OS |
| Molecular Weight | 580.68 g/mol |
| Exact Mass | 580.22 |
| IUPAC Name | 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide |
| SMILES | CN1CCN(Cc2ccc(C(=O)NCCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1 |
| InChI | InChI=1S/C30H31F3N6OS/c1-38-13-15-39(16-14-38)20-22-6-5-21(18-26(22)30(31,32)33)29(40)35-12-17-41-24-8-9-25-27(36-37-28(25)19-24)10-7-23-4-2-3-11-34-23/h2-11,18-19H,12-17,20H2,1H3,(H,35,40)(H,36,37)/b10-7+ |
| InChIKey | QUXOZLJIGJTPHD-JXMROGBWSA-N |
| XLogP | 5.42 |
| TPSA | 77.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 580.68 |
| LogP ≤ 5 | 5.42 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide?
The IUPAC name of 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide (CID 155517824) is 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide.
What is the SMILES notation for 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide?
The canonical SMILES for 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide is CN1CCN(Cc2ccc(C(=O)NCCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1.
What is the InChIKey of 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide?
The InChIKey is QUXOZLJIGJTPHD-JXMROGBWSA-N. The full InChI is InChI=1S/C30H31F3N6OS/c1-38-13-15-39(16-14-38)20-22-6-5-21(18-26(22)30(31,32)33)29(40)35-12-17-41-24-8-9-25-27(36-37-28(25)19-24)10-7-23-4-2-3-11-34-23/h2-11,18-19H,12-17,20H2,1H3,(H,35,40)(H,36,37)/b10-7+.
What are the key properties of 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide?
4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide has a molecular weight of 580.68 g/mol, XLogP of 5.42, 9 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(4-methylpiperazin-1-yl)methyl]-N-[2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]ethyl]-3-(trifluoromethyl)benzamide is sourced from PubChem (CID 155517824), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).